PATENT CLAIM ANALYSIS

Application Number: 15745411
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
Compositions and methods are described in which the topical application of a toll-like receptor 7 agonist or a toll-like receptor 9 agonist at or near a subdermal vaccination site provides an enhanced response to the vaccination. The enhanced response can be an elevated antibody titer relative to an untreated but vaccinated subject, and/or development of cross-species immunity to species not present in the vaccinating composition.

Claim (Index 29):
The method of  claim 28 , wherein the toll-like receptor 7 agonist comprises imiquimod.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.36
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13163002', '14996446', '14465055', '12746397', '12103136']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7331316270990791
- 35 USC 102 Novelty (BERT): 0.514202406418848
- Combined Prediction Score: 0.711238705031056
- Mean Citation Score: 241.788242
- Max Citation Score: 245.8243
- Similarity Product: 142.54503437606692

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test